BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5332649)

  • 1. Serum levels of second component of complement in cancer patients.
    Southam CM; Siegel AH
    J Immunol; 1966 Sep; 97(3):331-7. PubMed ID: 5332649
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunological behavior of patients with malignant blood diseases].
    Luca N
    Stud Cercet Med Interna; 1973; 14(5):429-46. PubMed ID: 4202394
    [No Abstract]   [Full Text] [Related]  

  • 3. The investigation of the immunological reactivity of patients with haemoblastosis.
    Libánský J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1965; 84(2):172-89. PubMed ID: 4161254
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acquisitions and problems in the cellular and serum immunology of malignant blood diseases].
    CAJANO A; FAIELLA A
    Riv Emoter Immunoematol; 1960; 7():317-34. PubMed ID: 13689856
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blastic lymphocyte transformation caused by phytohemagglutinin in patients with lymphoproliferative diseases].
    Mantovani G; Petrini MT; Tognella S; Grifoni V
    Boll Soc Ital Biol Sper; 1972 Jul; 48(14):381-5. PubMed ID: 4628299
    [No Abstract]   [Full Text] [Related]  

  • 6. [Quantitative immunoglobulin determination in paraproteinemias, lymphogranulomatosis and lympho-reticulosarcomatosis].
    Patakfalvi A; Simon K; Horváth T; Böhm G
    Orv Hetil; 1971 Jan; 112(2):75-8. PubMed ID: 4924220
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tuberculin allergy and malignant diseases].
    Chollet P; Rey M
    Nouv Presse Med; 1973 Feb; 2(6):381. PubMed ID: 4569123
    [No Abstract]   [Full Text] [Related]  

  • 8. Delayed-type hypersensitivity and immunoglobulin levels in the course of chemotherapy of advanced malignant neoplasms.
    Singer Z; Salwa J
    Arch Immunol Ther Exp (Warsz); 1973; 21(2):239-47. PubMed ID: 4581915
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunologic deficiencies in malignant diseases of the lymphoma group and in multiple myeloma].
    Hartl W; Hayduk K
    Arch Klin Med; 1967 Nov; 214(1):54-69. PubMed ID: 4872039
    [No Abstract]   [Full Text] [Related]  

  • 10. Examinations of the bactericidal properties of the serum against gram-positive microbes in patients suffering from leukaemia, malignant lymphoma, myeloma and myelofibrosis.
    Libánský J; Jezková Z
    Experientia; 1964 Mar; 20(3):124-7. PubMed ID: 5322537
    [No Abstract]   [Full Text] [Related]  

  • 11. [Significance of the HL-A-antigensystem in tumor research].
    Kuwert E; Bertrams J
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1972; 78(2):204-18. PubMed ID: 4264844
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current trends in therapy and prophylaxis of immunological disorders in malignant hemoreticulopathies].
    Berceanu S; Gociu M
    Stud Cercet Med Interna; 1969; 10(3):197-208. PubMed ID: 4186583
    [No Abstract]   [Full Text] [Related]  

  • 13. [6 cases of second primary neoplasms].
    Ardiles A; Aldunate C; Lagos M; Larraín P; Martínez C; Olivares R
    Rev Med Chil; 1990 Nov; 118(11):1291-3. PubMed ID: 1967110
    [No Abstract]   [Full Text] [Related]  

  • 14. An overview of cancer immunology.
    Ritts RE; Neel HB
    Mayo Clin Proc; 1974 Feb; 49(2):118-31. PubMed ID: 4591299
    [No Abstract]   [Full Text] [Related]  

  • 15. Presence of serologically distinct protein in serum of cancer patients and pregnant women. An attempt to develop a diagnostic cancer test.
    Tal C; Halperin M
    Isr J Med Sci; 1970; 6(6):708-16. PubMed ID: 4326931
    [No Abstract]   [Full Text] [Related]  

  • 16. [Phytohaemagglutinin blastic transformation in cancerous patients (author's transl)].
    Garcia-Puche JL; Muñoz E; Garrido F; Osorio C
    Sangre (Barc); 1974; 19(2):161-5. PubMed ID: 4605863
    [No Abstract]   [Full Text] [Related]  

  • 17. Humoral cross immunity in patients with malignant tumors.
    Harlozinska A; Albert Z; Richter R; Singer Z; Salwa J
    Arch Immunol Ther Exp (Warsz); 1971; 19(6):835-49. PubMed ID: 4946994
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunoglobulin composition of the blood in hemolymphoblastosis].
    Medina F; Tognella S
    Folia Allergol (Roma); 1967; 14(6):447-52. PubMed ID: 4171226
    [No Abstract]   [Full Text] [Related]  

  • 19. [Passive transmission of the tuberculin allergy in sarcoidosis and in malignant lymphomas].
    Kohout J
    Wien Klin Wochenschr; 1967 Oct; 79(43):795-8. PubMed ID: 4872281
    [No Abstract]   [Full Text] [Related]  

  • 20. Lymphocyte sensitivity and cellular immunity in neoplasia.
    Faguet GB; Balcerzak SP; Lobuglio AF
    Biomedicine; 1973 Feb; 19(2):43-7. PubMed ID: 4731978
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.